
    
      Group 1 (Luminal A):

        -  Standard treatment: Epirubicin (E) 90 mg/ m2 intravenous (iv) in combination with
           Cyclophosphamide (C) 600 mg/ m2 iv every 21 days for 4 cycles, followed by docetaxel
           (D)100 mg/m2 iv every 21 days for 4 cycles.

      EC x 4 -> D x 4

        -  Selective treatment: Postmenopausal patients: exemestane x 6 months; Premenopausal
           patients: goserelin x 6 months + exemestane x 6 months

      Group 2 (Basal):

        -  Standard treatment: EC x 4 -> D x 4

        -  Selective treatment: E 90 mg/ m2 iv in combination with C 600 mg/ m2 iv every 21 days
           for 4 cycles, followed by D (75 mg/m2) and carboplatin (Cb) (area under the curve = 6
           mg/mL) iv every 21 days for 4 cycles.

      EC x 4 -> DCb x 4
    
  